<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> thromboembolic <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> (CTE-PH) is an infrequent cause of <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> that develops in 0.1-0.2% of patients who survive after an <z:hpo ids='HP_0011009'>acute</z:hpo> venous thromboembolic event </plain></SENT>
<SENT sid="1" pm="."><plain>According to the largest series so far reported, 15-30% of patients with diagnosis of CTE-PH have an underlying congenital or acquired <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable state</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>To determine the prevalence of thrombophilic factors in our population, we analyzed 24 patients admitted to our institution between November 1992 and March 2000 fulfilling criteria for CTE-PH </plain></SENT>
<SENT sid="3" pm="."><plain>Eighteen patients disclosed abnormal results in the screening for <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (<z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and/or anticardiolipin antibodies) was the abnormality most frequently found (12 out of 24 patients) </plain></SENT>
<SENT sid="5" pm="."><plain>We found <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinaemia</z:e> in 7/14, true <z:e sem="disease" ids="C0242666" disease_type="Disease or Syndrome" abbrv="">protein S deficiency</z:e> in 1/10, <z:hpo ids='HP_0005543'>protein C deficiency</z:hpo> in 1/13, activated protein C resistance in 1/22, <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo> in 1/24, and prothrombin gene G20210A mutation in 1/18 patients </plain></SENT>
<SENT sid="6" pm="."><plain>Factor V Leiden was <z:mpath ids='MPATH_458'>normal</z:mpath> in <z:hpo ids='HP_0000001'>all</z:hpo> 18 patients studied </plain></SENT>
<SENT sid="7" pm="."><plain>Five patients (20.8%) disclosed more than one thrombophilic abnormality </plain></SENT>
<SENT sid="8" pm="."><plain>In conclusion, contrary to the largest series of patients with CTE-PH so far reported, we found that 75% of patients with CTE-PH presented at least one thrombophilic risk factor, being <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> in 50% of the cases </plain></SENT>
<SENT sid="9" pm="."><plain>We recommend a thorough screening for <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> in <z:hpo ids='HP_0000001'>all</z:hpo> patients with diagnosis of CTE-PH </plain></SENT>
</text></document>